1-3 of 3
Julie Teruya-Feldstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms

Emily C. Wheeler, Shailee Vora, Daniel Mayer, Andriana G. Kotini, Malgorzata Olszewska, Samuel S. Park, Ernesto Guccione, Julie Teruya-Feldstein, Lewis Silverman, Roger K. Sunahara, Gene W. Yeo, Eirini P. Papapetrou
Journal: Cancer Discovery
Cancer Discov (2022) 12 (3): 836–855.
https://doi.org/10.1158/2159-8290.CD-21-0508
Published: 08 March 2022
View article titled, Integrative RNA-omics Discovers <em>GNAS</em> Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms
Open the PDF for Integrative RNA-omics Discovers <em>GNAS</em> Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms in another window
Includes: Supplementary data
Journal Articles

JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response

Maria Kleppe, Minsuk Kwak, Priya Koppikar, Markus Riester, Matthew Keller, Lennart Bastian, Todd Hricik, Neha Bhagwat, Anna Sophia McKenney, Efthymia Papalexi, Omar Abdel-Wahab, Raajit Rampal, Sachie Marubayashi, Jonathan J. Chen, Vincent Romanet, Jordan S. Fridman, Jacqueline Bromberg, Julie Teruya-Feldstein, Masato Murakami, Thomas Radimerski, Franziska Michor, Rong Fan, Ross L. Levine
Journal: Cancer Discovery
Cancer Discov (2015) 5 (3): 316–331.
https://doi.org/10.1158/2159-8290.CD-14-0736
Published: 05 March 2015
View article titled, JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Open the PDF for JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response in another window
Includes: Supplementary data
Journal Articles

RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas

Georgia Konstantinidou, Giorgio Ramadori, Francesca Torti, Kim Kangasniemi, Rachel E. Ramirez, Yiran Cai, Carmen Behrens, Michael T. Dellinger, Rolf A. Brekken, Ignacio I. Wistuba, Adriana Heguy, Julie Teruya-Feldstein, Pier Paolo Scaglioni
Journal: Cancer Discovery
Cancer Discov (2013) 3 (4): 444–457.
https://doi.org/10.1158/2159-8290.CD-12-0388
Published: 10 April 2013
View article titled, RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
Open the PDF for RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas in another window
Includes: Supplementary data